Chengdu Easton Biopharmaceuticals Co Ltd (688513) — Cash Flow Quality Index
Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Cash Flow Quality Index of 0.73x as of September 2025. Operating cash flow of CN¥61.35 Million is below net income of CN¥83.59 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Chengdu Easton Biopharmaceuticals Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Chengdu Easton Biopharmaceuticals Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Chengdu Easton Biopharmaceuticals Co Ltd (688513) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Year-by-year earnings quality comparison for Chengdu Easton Biopharmaceuticals Co Ltd. For live market cap and the full company financial profile, see how much is Chengdu Easton Biopharmaceuticals Co Ltd worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | CN¥264.94 Million | CN¥283.25 Million | ▼ -15.3% |
| 2024 | 1.10x | CN¥263.24 Million | CN¥238.23 Million | ▼ -9.0% |
| 2023 | 1.21x | CN¥275.25 Million | CN¥226.57 Million | ▲ +97.1% |
| 2022 | 0.62x | CN¥151.94 Million | CN¥246.52 Million | ▼ -2.9% |
| 2021 | 0.64x | CN¥147.60 Million | CN¥232.43 Million | ▼ -27.7% |
| 2020 | 0.88x | CN¥156.52 Million | CN¥178.16 Million | ▼ -32.7% |
| 2019 | 1.31x | CN¥141.83 Million | CN¥108.61 Million | ▲ +5.7% |
| 2018 | 1.24x | CN¥166.79 Million | CN¥135.02 Million | ▼ -7.2% |
| 2017 | 1.33x | CN¥85.70 Million | CN¥64.37 Million | ▼ -28.0% |
| 2016 | 1.85x | CN¥106.06 Million | CN¥57.32 Million | ▲ +37.7% |
| 2015 | 1.34x | CN¥50.57 Million | CN¥37.62 Million | ▼ -15.9% |
| 2014 | 1.60x | CN¥46.71 Million | CN¥29.23 Million | ▼ -16.3% |
| 2013 | 1.91x | CN¥28.12 Million | CN¥14.73 Million | — |